Institutional investors hold a majority ownership of ABT through the 73.28% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Medical Specialties industry. Last, during the quarter ended March 2017, these large investors purchased a net $59.8 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HEXAVEST, INC. Bought 1.1 Million shares of Abbott Laboratories
NORTHERN TRUST GLOBAL INVESTMENT... Bought 401.5 Thousand shares of Abbott Laboratories